• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.乳腺癌的多学科筛查、诊断、治疗及随访。德国妇科和产科学会(DGGG)与德国癌症协会(DKG)指南(S3级别,德国医学科学协会注册编号032/045OL,2017年12月)——第1部分:乳腺癌筛查、诊断及治疗建议
Geburtshilfe Frauenheilkd. 2018 Oct;78(10):927-948. doi: 10.1055/a-0646-4522. Epub 2018 Oct 19.
2
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer.乳腺癌的多学科筛查、诊断、治疗及随访。德国妇科和产科学会(DGGG)与德国癌症协会(DKG)指南(S3级,德国医学科学信息平台AWMF注册号032/045OL,2017年12月) - 第2部分:原发性、复发性和晚期乳腺癌治疗建议
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1056-1088. doi: 10.1055/a-0646-4630. Epub 2018 Nov 26.
3
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.子宫内膜癌。德国妇科和产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇产医院协会(DKH)指南(S3级,德国医学科学与健康照护品质促进协会(AWMF)登记编号032/034-OL,2022年9月)。第1部分:关于子宫内膜癌的流行病学、筛查、诊断和遗传因素、老年评估及供应结构的建议
Geburtshilfe Frauenheilkd. 2023 Aug 15;83(8):919-962. doi: 10.1055/a-2066-2051. eCollection 2023 Aug.
4
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.子宫内膜癌。德国妇科与产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇科与产科学会(DKH)指南(S3级,德国医学科学院注册编号032/034-OL,2022年9月) - 第2部分,关于癌前病变和早期子宫内膜癌的治疗、手术治疗、放射治疗和药物治疗、随访、复发与转移、心理肿瘤护理、姑息治疗、患者教育以及康复和物理治疗的建议。
Geburtshilfe Frauenheilkd. 2023 Aug 15;83(8):963-995. doi: 10.1055/a-2066-2068. eCollection 2023 Aug.
5
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.子宫内膜癌患者的多学科诊断、治疗及随访。指南(S3级,德国医学专业协会登记编号032/034-OL,2018年4月)——第1部分:关于子宫内膜癌的流行病学、筛查、诊断及遗传因素的建议
Geburtshilfe Frauenheilkd. 2018 Oct;78(10):949-971. doi: 10.1055/a-0713-1218. Epub 2018 Oct 19.
6
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.子宫内膜癌患者的多学科诊断、治疗与随访。指南(S3级,德国医学专业协会注册编号032/034-OL,2018年4月) - 第2部分:关于子宫内膜癌的治疗与随访、姑息治疗、心理肿瘤学/心理社会护理/康复/患者信息及医疗设施的建议
Geburtshilfe Frauenheilkd. 2018 Nov;78(11):1089-1109. doi: 10.1055/a-0715-2964. Epub 2018 Nov 26.
7
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy.子宫颈癌的诊断、治疗与随访。德国妇科与产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇科与产科学会健康保险分会(DKH)指南(S3级,德国医学科学院质量与效率医学研究所登记号:032/033OL,2021年5月)——第1部分:关于流行病学、筛查、诊断与治疗的建议
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):139-180. doi: 10.1055/a-1671-2158. eCollection 2022 Feb.
8
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.子宫颈癌的诊断、治疗与随访。德国妇科与产科学会、德国癌症协会和德国妇科与产科学会指南(S3级,德国医学科学与医学质量评估委员会登记号032/033OL,2021年5月) - 第2部分:关于心理肿瘤学、康复、随访、复发、姑息治疗和医疗设施的建议
Geburtshilfe Frauenheilkd. 2022 Feb 11;82(2):181-205. doi: 10.1055/a-1671-2446. eCollection 2022 Feb.
9
Hormonal Contraception. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry Number 015/015, January 2020).激素避孕。德国妇产科学会、奥地利妇产科学会和瑞士妇产科学会指南(S3 级,德国医学专业协会注册号 015/015,2020 年 1 月)
Geburtshilfe Frauenheilkd. 2021 Feb;81(2):152-182. doi: 10.1055/a-1259-1609. Epub 2021 Feb 8.
10
Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.外阴癌及其前驱病变的诊断、治疗与随访。德国妇科和产科学会(DGGG)及德国妇科肿瘤学会(DKG)指南(S2k级别,德国医学科学院质量与效益研究所登记号015/059,2015年11月)
Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1035-1049. doi: 10.1055/s-0042-103728.

引用本文的文献

1
Improving quality of care for cancer patients through oncological second opinions in a Comprehensive Cancer Center: adherence to second-opinion therapy recommendations.在综合癌症中心通过肿瘤学二次诊疗意见提高癌症患者的护理质量:对二次诊疗意见治疗建议的依从性。
J Cancer Res Clin Oncol. 2025 Apr 2;151(4):130. doi: 10.1007/s00432-025-06149-2.
2
Interdisciplinary Management of Cardiotoxicity in Outpatient Settings: A Survey on Practices, Perceptions and Potential for Improvement.门诊环境中心脏毒性的跨学科管理:关于实践、认知及改进潜力的调查
Eur Cardiol. 2025 Feb 13;20:e02. doi: 10.15420/ecr.2023.49. eCollection 2025.
3
Quality-of-Life Assessment in Patients Undergoing Mastectomy and Breast Reconstruction for Moderate-Penetrance Gene-Related Breast Cancer.中度遗传易感性基因相关乳腺癌患者乳房切除术后乳房重建的生活质量评估
J Clin Med. 2025 Feb 10;14(4):1140. doi: 10.3390/jcm14041140.
4
Impact of CCND1 amplification on the prognosis of hormone receptor-positive, HER2-negative breast cancer patients-correlation of clinical and pathological markers.CCND1基因扩增对激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者预后的影响——临床与病理标志物的相关性
Breast Cancer Res Treat. 2025 Feb;210(1):125-134. doi: 10.1007/s10549-024-07545-x. Epub 2024 Nov 26.
5
Can Ki-67 serve as a suitable marker to indicate the necessity of staging diagnostics in cases of low-risk breast cancer?在低风险乳腺癌病例中,Ki-67能否作为一个合适的标志物来指示进行分期诊断的必要性?
Arch Gynecol Obstet. 2025 Feb;311(2):443-449. doi: 10.1007/s00404-024-07753-2. Epub 2024 Oct 30.
6
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer.免疫组织化学 3 评分在淋巴结阴性、激素受体阳性、HER2 阴性早期乳腺癌患者中的预后预测。
ESMO Open. 2024 Nov;9(11):103963. doi: 10.1016/j.esmoop.2024.103963. Epub 2024 Oct 26.
7
Clinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwide.乳腺X线密度管理临床指南:全球乳腺筛查指南的系统评价
JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae103.
8
Correlation of preoperative sonographic staging and postoperative histopathologic staging in patients with invasive breast cancer.术前超声分期与浸润性乳腺癌患者术后组织病理分期的相关性。
Arch Gynecol Obstet. 2024 Nov;310(5):2623-2630. doi: 10.1007/s00404-024-07699-5. Epub 2024 Sep 2.
9
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients.原发性乳腺癌患者 RANK 和 RANKL 与乳腺 X 线摄影密度的相关性。
Arch Gynecol Obstet. 2024 Aug;310(2):1223-1233. doi: 10.1007/s00404-024-07495-1. Epub 2024 Jun 5.
10
Management of Patients with Breast Biopsy under Anti-Coagulation or Anti-Platelet Therapy: Results of a Survey of German Experts.接受抗凝或抗血小板治疗的乳腺活检患者的管理:德国专家调查结果
Breast Care (Basel). 2024 Apr;19(2):87-94. doi: 10.1159/000536079. Epub 2024 Jan 10.

本文引用的文献

1
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.BRCA1和BRCA2突变携带者的双侧卵巢切除术与乳腺癌风险
J Natl Cancer Inst. 2016 Sep 6;109(1). doi: 10.1093/jnci/djw177. Print 2017 Jan.
2
Body Fatness and Cancer--Viewpoint of the IARC Working Group.身体肥胖与癌症——国际癌症研究机构工作组的观点
N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602.
3
Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis.乳腺磁共振成像在非钙化性乳腺可疑病变中的诊断效能:一项系统评价与Meta分析的结果
PLoS One. 2016 Aug 2;11(8):e0160346. doi: 10.1371/journal.pone.0160346. eCollection 2016.
4
Systematic review of 3D mammography for breast cancer screening.用于乳腺癌筛查的三维乳腺摄影术的系统评价
Breast. 2016 Jun;27:52-61. doi: 10.1016/j.breast.2016.01.002. Epub 2016 Mar 25.
5
The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy.MRI在接受保乳治疗的女性随访中的作用
Am J Clin Oncol. 2016 Jun;39(3):314-9. doi: 10.1097/COC.0000000000000290.
6
[Not Available].[无可用内容]。
Rofo. 2016 Apr;188(4):346-52. doi: 10.1055/s-0042-101847. Epub 2016 Mar 22.
7
Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review.预防性手术在 BRCA1 或 BRCA2 基因突变携带者中的效果:一项荟萃分析和系统评价。
Clin Cancer Res. 2016 Aug 1;22(15):3971-81. doi: 10.1158/1078-0432.CCR-15-1465. Epub 2016 Mar 15.
8
Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts: Interim Report of a Prospective Comparative Trial.乳腺钼靶检查阴性的致密型乳腺女性采用断层合成或超声进行辅助筛查:一项前瞻性比较试验的中期报告
J Clin Oncol. 2016 Jun 1;34(16):1882-1888. doi: 10.1200/JCO.2015.63.4147. Epub 2016 Mar 9.
9
Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.21401个乳腺癌和卵巢癌家族中BRCA1/2种系突变的患病率
J Med Genet. 2016 Jul;53(7):465-71. doi: 10.1136/jmedgenet-2015-103672. Epub 2016 Feb 29.
10
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.乳腺癌筛查:美国预防服务工作组推荐声明。
Ann Intern Med. 2016 Feb 16;164(4):279-96. doi: 10.7326/M15-2886. Epub 2016 Jan 12.

乳腺癌的多学科筛查、诊断、治疗及随访。德国妇科和产科学会(DGGG)与德国癌症协会(DKG)指南(S3级别,德国医学科学协会注册编号032/045OL,2017年12月)——第1部分:乳腺癌筛查、诊断及治疗建议

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer.

作者信息

Wöckel Achim, Festl Jasmin, Stüber Tanja, Brust Katharina, Stangl Stephanie, Heuschmann Peter U, Albert Ute-Susann, Budach Wilfried, Follmann Markus, Janni Wolfgang, Kopp Ina, Kreienberg Rolf, Kühn Thorsten, Langer Thomas, Nothacker Monika, Scharl Anton, Schreer Ingrid, Link Hartmut, Engel Jutta, Fehm Tanja, Weis Joachim, Welt Anja, Steckelberg Anke, Feyer Petra, König Klaus, Hahne Andrea, Kreipe Hans H, Knoefel Wolfram Trudo, Denkinger Michael, Brucker Sara, Lüftner Diana, Kubisch Christian, Gerlach Christina, Lebeau Annette, Siedentopf Friederike, Petersen Cordula, Bartsch Hans Helge, Schulz-Wendtland Rüdiger, Hahn Markus, Hanf Volker, Müller-Schimpfle Markus, Henscher Ulla, Roncarati Renza, Katalinic Alexander, Heitmann Christoph, Honegger Christoph, Paradies Kerstin, Bjelic-Radisic Vesna, Degenhardt Friedrich, Wenz Frederik, Rick Oliver, Hölzel Dieter, Zaiss Matthias, Kemper Gudrun, Budach Volker, Denkert Carsten, Gerber Bernd, Tesch Hans, Hirsmüller Susanne, Sinn Hans-Peter, Dunst Jürgen, Münstedt Karsten, Bick Ulrich, Fallenberg Eva, Tholen Reina, Hung Roswita, Baumann Freerk, Beckmann Matthias W, Blohmer Jens, Fasching Peter A, Lux Michael P, Harbeck Nadia, Hadji Peyman, Hauner Hans, Heywang-Köbrunner Sylvia, Huober Jens, Hübner Jutta, Jackisch Christian, Loibl Sibylle, Lück Hans-Jürgen, von Minckwitz Gunter, Möbus Volker, Müller Volkmar, Nöthlings Ute, Schmidt Marcus, Schmutzler Rita, Schneeweiss Andreas, Schütz Florian, Stickeler Elmar, Thomssen Christoph, Untch Michael, Wesselmann Simone, Bücker Arno, Krockenberger Mathias

机构信息

Universitätsfrauenklinik Würzburg, Universität Würzburg, Würzburg, Germany.

Institut für Klinische Epidemiologie und Biometrie (IKE-B), Universität Würzburg, Würzburg, Germany.

出版信息

Geburtshilfe Frauenheilkd. 2018 Oct;78(10):927-948. doi: 10.1055/a-0646-4522. Epub 2018 Oct 19.

DOI:10.1055/a-0646-4522
PMID:30369626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6202580/
Abstract

The aim of this official guideline coordinated and published by the German Society for Gynecology and Obstetrics (DGGG) and the German Cancer Society (DKG) was to optimize the screening, diagnosis, therapy and follow-up care of breast cancer. The process of updating the S3 guideline dating from 2012 was based on the adaptation of identified source guidelines which were combined with reviews of evidence compiled using PICO (Patients/Interventions/Control/Outcome) questions and the results of a systematic search of literature databases and the selection and evaluation of the identified literature. The interdisciplinary working groups took the identified materials as their starting point to develop recommendations and statements which were modified and graded in a structured consensus procedure. Part 1 of this short version of the guideline presents recommendations for the screening, diagnosis and follow-up care of breast cancer. The importance of mammography for screening is confirmed in this updated version of the guideline and forms the basis for all screening. In addition to the conventional methods used to diagnose breast cancer, computed tomography (CT) is recommended for staging in women with a higher risk of recurrence. The follow-up concept includes suggested intervals between physical, ultrasound and mammography examinations, additional high-tech diagnostic procedures, and the determination of tumor markers for the evaluation of metastatic disease.

摘要

由德国妇产科学会(DGGG)和德国癌症协会(DKG)共同协调并发布的这份官方指南,旨在优化乳腺癌的筛查、诊断、治疗及后续护理。2012年S3指南的更新过程,是基于对已确定的源指南进行调整,并结合使用PICO(患者/干预措施/对照/结局)问题编制的证据综述,以及对文献数据库进行系统检索的结果,还有对所确定文献的筛选和评估。跨学科工作组以所确定的材料为起点,制定建议和声明,并在结构化的共识程序中进行修改和分级。本指南简版的第1部分给出了乳腺癌筛查、诊断及后续护理的建议。本指南的更新版本确认了乳腺钼靶筛查的重要性,并将其作为所有筛查的基础。除了用于诊断乳腺癌的传统方法外,对于复发风险较高的女性,建议采用计算机断层扫描(CT)进行分期。后续护理方案包括建议的体格检查、超声检查和乳腺钼靶检查之间的间隔时间、额外的高科技诊断程序,以及用于评估转移性疾病的肿瘤标志物测定。